Navigation Links
Group Practice Forum Launches Fromer-GPF Patient Journey Providing Physicians with Simple Solutions to Improve Patient Care
Date:7/8/2010

NEW YORK, July 8 /PRNewswire/ -- Group Practice Forum (GPF), an independent network of medical professionals, today announced the official launch of the Fromer-GPF Patient Journey, a proprietary workflow solution designed to provide primary care physicians with simple solutions to improve patient care.  The Journey was developed by the Executive Medical Director of GPF, Len Fromer, M.D., FAAFP, who also serves as Assistant Clinical Professor of Family Medicine at University of California at Los Angeles School of Medicine and Western University of Health Sciences.  

The Fromer-GPF Patient Journey is a team-based model that equips primary care physicians treating patients with chronic diseases with valuable tools that can be integrated into their practices immediately.  Using the Journey model, physicians and their patients can gain practical solutions to incorporate into a chronic disease care model; methods to improve patients' health literacy; improved quality of the patient-physician dialogue; and an enhanced journey to physician-supervised patient self-management.

"Primary care in the United States is currently in crisis. With misaligned financial incentives and an insufficient number of providers, we have an unsatisfactory system for both physicians and patients," said Dr. Fromer. "By arming healthcare providers with the tools they need, the Fromer GPF Patient Journey addresses the chronic care crisis, and improves quality of care for patients with chronic diseases.  Both physicians and patients can benefit greatly from the patient-centered, high-performing practice achieved by deploying the Journey model."


'/>"/>
SOURCE Group Practice Forum
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Central Penn Management Group Selects Allscripts Electronic Health Record for Physicians Alliance
2. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
3. Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction
4. Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
5. Elsevier Appoints Martin OMalley as Managing Director of New Global Sales Group in Science & Technology Division
6. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
7. Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million
8. Riverside Health System Benefits from New Model of Care Facilitation Powered by Curaspan Health Group
9. Collaborating with Patient Advocacy Groups to Educate Physicians, Patients and Thought Leaders
10. Encision and HealthTrust Purchasing Group Sign Purchasing Agreement
11. Winner Medical Group Inc. Announces Exercise of Over-Allotment Option Bringing Aggregate Net Proceeds of the Public Offering to $8.8 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Mass., July 29, 2014 Cynosure, Inc. ... markets laser- and light-based aesthetic treatment systems for high-volume ... ended June 30, 2014. Second-quarter 2014 financial results incorporate ... on June 24, 2013. Second-Quarter ... increased 45% to $72.6 million , Non-GAAP net ...
(Date:7/29/2014)... 29, 2014   ... will present data from a Phase I clinical trial ... or stop Parkinson,s disease progression. The Michael J. Fox ... and will discuss the impact of the results for ... Thursday, July 31, 2014       ...
(Date:7/29/2014)... 2014  Drug development for hepatitis C virus ... and the intense need for curative therapy in ... underway as the market moves away from protease ... interferon-free oral therapies. Logo - ... blockbuster Sovaldi is the first of these novel ...
Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4
... May 2, 2012 Janssen Research & Development, LLC, ... Drug Applications (sNDAs) to the U.S. Food and Drug ... ® (rivaroxaban), an oral anticoagulant, to treat patients ... and prevention of recurrent venous thromboembolism (VTE). ...
... Official journal of the American Association for ... of scientific, technical and medical information products and services, announces ... American Association for Geriatric Psychiatry (AAGP) to publish ... AJGP ) beginning in January 2013. "We are ...
Cached Medicine Technology:Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism 2Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism 3Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism 4Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism 5Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism 6Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism 7Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism 8Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry 2Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry 3
(Date:7/29/2014)... July 29, 2014 truBrain has created ... provided by energy drinks. Think Drinks , available ... that creates optimal conditions for memory, complex reasoning and ... hopes to raise $50,000 over the course of the ... mental boost and have compounding effects over time when ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Outsourced ... of tripling in the number of hospitals contracting ... 1, 2015 deadline, according to the recently published ... physician leaders, found in the reports “Top Ranked ... hospitals now outsource Clinical documentation audit, review and ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Biocides are ... and control bacteria or fungi growth and to prevent ... within the material and its surface. It is used ... wood preservation, food and beverage, paints and coatings. It ... and sanitizers, as well as in industrial applications to ...
(Date:7/29/2014)... increasing use of electronic medical records and health ... a computerized version of the preventive care guidelines ... new study, researchers from the Indiana University School ... substantial work lies ahead to convert the American ... prompts for physicians, but the payoff has the ...
(Date:7/29/2014)... 29, 2014 The Latin American poultry feed ... with analysis and forecast of revenue. The poultry feed and ... from $25,273.3 million and $647.2 million in 2013 to $34,024.0 ... 6.1% from 2013 to 2018, respectively. , To get an ... the TOC of the Latin American poultry feed and feed ...
Breaking Medicine News(10 mins):Health News:Focus- and Productivity-Enhancing Beverage Launches Crowdfunding Campaign on Indiegogo 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5
... be done without destroying embryo , , WEDNESDAY, July 9 ... in developing human embryonic stem cells earlier in the ... embryo, so the whole embryo is not destroyed. , ... European Society of Human Reproduction & Embryology annual conference ...
... Chest Pain Centers (SCPC) have been shown to perform ... Centers for Medicare and Medicaid Services (CMS) as compared ... by an Emory University researcher. , The ... director for observation medicine in the Emory University School ...
... Holdings, Inc.,(NYSE and SWX: ZMH) announced today its second ... live over the Internet on,Thursday, July 24, 2008, at ... results will be made available at 7:00 a.m. the,morning ... can be accessed via Zimmer,s Investor Relations,website at ...
... it comes to the attractiveness of orthodontic braces, less metal ... of the public,s attitude about the attractiveness of various styles ... no visible metal were considered the most attractive. Braces that ... were a less desirable option, and braces with metal brackets ...
... WEDNESDAY, July 9 (HealthDay News) -- Being born extremely underweight ... as an adult. , A study published in the July ... were born at extremely low birth weights were more likely ... had been born at normal weights. , And that ...
... - DaVita Medical Missions Reaches Out to Patients in Need of ... ... Bridge of Life - DaVita,Medical Missions(TM), a non-profit organization founded by DaVita ... to its newest dialysis clinic in India in late,June. The new clinic ...
Cached Medicine News:Health News:New Technique Harvests Stem Cells at Earlier Stage 2Health News:New Technique Harvests Stem Cells at Earlier Stage 3Health News:Chest pain center accreditation linked with better outcomes in heart attack patients 2Health News:Survey: Most effective dental braces are least attractive 2Health News:Survey: Most effective dental braces are least attractive 3Health News:Do Underweight Newborns Make for Shy Adults? 2Health News:U.S. Non-Profit Brings Life-Saving Dialysis Treatment to India 2Health News:U.S. Non-Profit Brings Life-Saving Dialysis Treatment to India 3
... Chalam 15° Prism are designed ... are recommended for tractional retinal ... Rhegmatogenus retinal detachment. They can ... and other midperipheral laser applications. ...
... The High-Mag 1.5x ... internal limiting membrane peeling ... optic nerve neurotomy, sheathotomy ... traditional macular edema and ...
... visualization of virtually the entire retina including ... of the lens on the eye. It ... giant retinal tears, diagnosing and treating anterior ... retina in a vitreous cavity filled with ...
... higher magnification and increased stereopsis, ... suited for detailed visualization to ... Retinal is ideal for vitrectomy ... peeling in proliferative vitreoretinopathy extending ...
Medicine Products: